Endothelin receptor antagonism improves lipid profiles & lowers PCSK9 in patients with chronic kidney disease

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalHypertension
DOIs
Publication statusPublished - 10 Jun 2019

Cite this